Myomo (MYO) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY25 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Myomo (MYO) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY25 Revenue Guidance

Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million

March 10, 2025 4:05 PM EDT

Generated first-ever positive quarterly cash flow from operations
Received a record 233 MyoPro® authorizations and orders with 657 additions to the pipeline

Introduces 2025 revenue guidance of $50 million to $53 million
Conference call being held today at 4:30pm Eastern time

BURLINGTON, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (Myomo or the Company), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31,... More